Cynata Therapeutics Ltd has released a press release.
CYP MSC Data in Asthma Model Published in Sceintific Journal
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Cynata Files New Patent Application for Cymerus in Oncology
- United States Patent for Core Cynata Technology
- Treatment Commences in Cynatas World First Clinical Trial
- March 2017 Quarterly Report
- Cynata Advances to Pre-IND Meeting with US FDA
Later from Cynata Therapeutics
- Cynata Therapeutics GvHD Clinical Trial & Corporate Progress
- FDA Meeting Provides Clear Path for US Development Plans
- June 2017 Quarterly Report
- Positive Data from CYP MSCs in 2nd Preclinical Asthma Study
- Health Canada Meeting Advances CYP Global Development Plans
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics